With the public availability of ChatGPT 3.5 in fall 2022 at the latest, artificial intelligence in the sense of large language models (LLMs) is on everyone’s lips. However, it is often forgotten that this is only the provisional end point of decades of development of artificial intelligence, which, despite its great potential, still has many limitations. The question for practising doctors is how this technology can be used sensibly in everyday clinical practice – and how it should not be used.
Autoren
- Dr. med. Lukas Dürst
- Dr. med. Marc Oertle
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Pathogenesis, diagnostics and therapeutic interventions
Sarcopenia in Parkinson’s disease
- Casuistry
63-year-old with tracheobronchopathia osteoplastica
- 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline
Management of acute coronary syndrome
- Pustular psoriasis
What is known about inflammatory mechanisms in PPP and GPP?
- Diabetes-related cardiovascular diseases
Ferroptosis: key mechanisms and novel therapeutic approaches
- Atrial fibrillation
What’s new with the “pace-and-ablate” strategy?
- De-escalation strategies
De-escalation strategies – less is more
- Pathogens in the brain